SCHEMBL8484254

SCHEMBL8484254

N#Cc1ccccc1-c1ccc2cc(CBr)ccc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.40
HRH3 Q9Y5N1 3/20 0.40
GAA P10253 3/20 0.37
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
GRM2 Q14416 1/20 0.37
ACP1 P24666 1/20 0.36
MET P08581 1/20 0.36
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
MAPK1 P28482 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CLK4 Q9HAZ1 2/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8482877 0.79 KDM4E (0.47) GAAALDH1A1KDM4EGRM2MET
SCHEMBL21483572 0.78 NPC1 (0.50) GAAALDH1A1KDM4EGRM2CYP1A2
SCHEMBL8486934 0.77 TRPA1 (0.49) HRH3ALDH1A1GABRG2GABRB3GABRA5
SCHEMBL7014676 0.76 PTGES (0.40) GAAALDH1A1GRM2GABRG2GABRB3
SCHEMBL11814702 0.75 MAOA (0.47) KCNH2HRH3ALDH1A1KDM4EMET
SCHEMBL8929477 0.75 RAB9A (0.44) KDM4EMEN1KMT2APPARG
SCHEMBL7795534 0.75 ESR2 (0.41) ALDH1A1KDM4EGABRG2GABRB3GABRA5
SCHEMBL16881222 0.73 NQO1 (0.54) KCNH2HRH3GAAALDH1A1KDM4E
SCHEMBL8809279 0.71 PLAU (0.41) KCNH2GAAGRM2METGABRG2
SCHEMBL9269982 0.71 MAPT (0.44) GAAALDH1A1KDM4EHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5955487-A TREATING HIGH BLOOD PRESSURE, CARDIAC INSUFFICIENCY, GLAUCOMA CIBA-GEIGY CORPORATION (US) 1999-09-21 US disclosed
EP-0528762-B1 N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists CIBA GEIGY AG (CH) 1997-05-07 EP disclosed
US-5620998-A CARDIOVASCULAR DISORDERS; HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1997-04-15 US disclosed
US-5506240-A HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1996-04-09 US disclosed
EP-0528762-A1 N-acyl-N-heterocyclyl- or naphthyl-alkyl amino acids as angiotensin II antagonists CIBA-GEIGY AG (CH) 1993-02-24 EP disclosed